Letter to the editor: Successful treatment of multidrug resistant hepatitis C after &gt;12 months of continuous therapy with direct‐acting antivirals

Trudeau, Sheri; Mendiratta, Vivek; Dababneh, Yara; Hollingsworth, Jennifer A.; Gordon, Stuart C.

doi:10.1002/hep.32688

Hepatology

2022

DOI: 10.1002/hep.32688

|View full text |Cite

Letter to the editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct‐acting antivirals

Sheri Trudeau

Vivek Mendiratta

Yara Dababneh

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2023

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 2 publications

(3 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We read the study by Trudeau et al, which presented a patient case with a history of multiple failed treatments who ultimately achieved sustained virological response (SVR) after an extended course of direct‐acting antiviral (DAA) regimens 1. However, we have some concerns about this conclusion.…”

mentioning

confidence: 99%

Letter to the editor: Successful treatment of multidrug‐resistant hepatis C after >12 months of continuous therapy with direct‐acting antivirals

Luo

Zhang

2022

Hepatology

View full text Add to dashboard Cite

mentioning

confidence: 99%

Letter to the editor: Successful treatment of multidrug‐resistant hepatis C after >12 months of continuous therapy with direct‐acting antivirals

Luo

Zhang

2022

Hepatology

View full text Add to dashboard Cite

Antivirals

2023

Reactions Weekly

View full text Add to dashboard Cite

Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases– Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

Aronsohn

Bhattacharya

et al. 2023

Clinical Infectious Diseases

View full text Add to dashboard Cite

The Infectious Diseases Society of America and the American Association for the Study of Liver Diseases have collaboratively developed evidence-based guidance regarding the diagnosis, management, and treatment of hepatitis C virus (HCV) infection since 2013. A panel of clinicians and investigators with extensive infectious diseases or hepatology expertise specific to HCV infection periodically review evidence from the field and update existing recommendations or introduce new recommendations as evidence warrants. This update focuses on changes to the guidance since the previous 2020 published update, including ongoing emphasis on recommended universal screening; management recommendations for incomplete treatment adherence; expanded eligibility for simplified chronic HCV infection treatment in adults with minimal monitoring; updated treatment and retreatment recommendations for children as young as 3 years old; management and treatment recommendations in the transplantation setting; and screening, treatment, and management recommendations for unique and key populations.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Letter to the editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct‐acting antivirals

Cited by 3 publications

References 2 publications

Letter to the editor: Successful treatment of multidrug‐resistant hepatis C after >12 months of continuous therapy with direct‐acting antivirals

Letter to the editor: Successful treatment of multidrug‐resistant hepatis C after >12 months of continuous therapy with direct‐acting antivirals

Antivirals

Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases– Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

Contact Info

Product

Resources

About